Crossmark

Acetazolamide Mitigates Intracranial Pressure Spikes Without Affecting Functional Outcome After Experimental Hemorrhagic Stroke

Crossref DOI link: https://doi.org/10.1007/s12975-018-0663-6

Published Online: 2018-09-17

Published Print: 2019-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Williamson, Michael R.

Wilkinson, Cassandra M.

Dietrich, Kristen

Colbourne, Frederick https://orcid.org/0000-0002-9567-2082
Funding

Funding for this research was provided by:

Heart and Stroke Foundation of Canada (G-16-00014065)

Canadian Institutes of Health Research
License Information

Text and Data Mining valid from 2018-09-17
More Information

Article History

Received: 29 August 2018

Accepted: 4 September 2018

First Online: 17 September 2018

Compliance with Ethical Standards

:

: The authors declare that they have no conflict of interest.

: All applicable international, national, and/or institutional guidelines for the care and use of animals were followed. Protocols conformed to Canadian Council of Animal Care Guidelines and were approved by the Biosciences Animal Care and Use Committee at the University of Alberta.